{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:03:29Z","timestamp":1785305009604,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["81571585"],"award-info":[{"award-number":["81571585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.clim.2017.03.017","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T17:47:20Z","timestamp":1491414440000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Autoantibodies, detection methods and panels for diagnosis of Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"182","author":[{"given":"Long","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmanan","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9482","key":"10.1016\/j.clim.2017.03.017_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.clim.2017.03.017_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2011.12.006","article-title":"Classification criteria for Sjogren's syndrome: a critical review","volume":"39","author":"Baldini","year":"2012","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritris Rheum."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ICO.0b013e31818d3846","article-title":"Evaluation of patients with dry eye for presence of underlying Sjogren syndrome","volume":"28","author":"Akpek","year":"2009","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6061\/clinics\/2014(03)02","article-title":"Sjogren's syndrome: an underdiagnosed condition in mixed connective tissue disease","volume":"69","author":"Usuba","year":"2014","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0030","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar4359","article-title":"Efficacy and safety of rituximab treatment in early primary Sjogren's syndrome: a prospective, multi-center, follow-up study","volume":"15","author":"Carubbi","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.clim.2017.03.017_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12016-007-8003-8","article-title":"Sjogren's syndrome\u2014study of autoantigens and autoantibodies","volume":"32","author":"Routsias","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.clim.2017.03.017_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/ard.43.2.243","article-title":"Autoantibodies in the sicca syndrome (primary Sjogren's syndrome)","volume":"43","author":"Elkon","year":"1984","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.clim.2017.03.017_bb0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/annrheumdis-2014-206683","article-title":"The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome","volume":"74","author":"Baer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.61.5.398","article-title":"Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro\/SSA, La\/SSB and their linear epitopes in primary Sjogren's syndrome (pSS): a European multicentre study","volume":"61","author":"Tzioufas","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"9 Pt 2","key":"10.1016\/j.clim.2017.03.017_bb0060","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/j.lpm.2012.05.022","article-title":"Autoantibodies in Sjogren's syndrome: clinical presentation and regulatory mechanisms","volume":"41","author":"Tzioufas","year":"2012","journal-title":"Presse Med."},{"issue":"4","key":"10.1016\/j.clim.2017.03.017_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sjogren's syndrome in the North East of England: a long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","author":"Nardi","year":"2006","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.clim.2017.03.017_bb0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0090","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10875-011-9553-3","article-title":"Active immunological profile is associated with systemic Sjogren's syndrome","volume":"31","author":"Martel","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0095","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2017.03.017_bb0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","article-title":"Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjogren's Syndrome: a retrospective analysis of 65 patients in the Netherlands","volume":"40","author":"ter Borg","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03009740802366043","article-title":"IgA rheumatoid factor in primary Sjogren's syndrome","volume":"38","author":"Peen","year":"2009","journal-title":"Scand. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.10.006","article-title":"IL-14 alpha, the nexus for primary Sjogren's disease in mice and humans","volume":"130","author":"Shen","year":"2009","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.03.017_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1752-1947-8-145","article-title":"Anti-salivary gland protein 1 antibodies in two patients with Sjogren's syndrome: two case reports","volume":"8","author":"Vishwanath","year":"2014","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.clim.2017.03.017_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12886-015-0023-1","article-title":"Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort","volume":"15","author":"Suresh","year":"2015","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.03.017_bb0135","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.clinbiochem.2013.04.020","article-title":"The accuracy of the anti-alpha-fodrin antibody test for diagnosis of Sjogren's syndrome: a meta-analysis","volume":"46","author":"Hu","year":"2013","journal-title":"Clin. Biochem."},{"issue":"5312","key":"10.1016\/j.clim.2017.03.017_bb0140","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.276.5312.604","article-title":"Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome","volume":"276","author":"Haneji","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/kel270","article-title":"Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to alpha-fodrin antibodies","volume":"46","author":"Willeke","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.clim.2017.03.017_bb0150","first-page":"363","article-title":"Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjogren's syndrome","volume":"28","author":"Kobayashi","year":"2001","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2017.03.017_bb0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00296-004-0568-4","article-title":"Anti-CENP-H antibodies in patients with Sjogren's syndrome","volume":"26","author":"Hsu","year":"2006","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.clim.2017.03.017_bb0160","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/ar2958","article-title":"Anticentromere antibody positive Sjogren's syndrome: a retrospective descriptive analysis","volume":"12","author":"Bournia","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.clim.2017.03.017_bb0165","first-page":"2253","article-title":"Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome","volume":"34","author":"Salliot","year":"2007","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2017.03.017_bb0170","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/ard.2005.046003","article-title":"Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma","volume":"65","author":"Gelber","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.clim.2017.03.017_bb0175","first-page":"2238","article-title":"Clinical and laboratory features of anticentromere antibody positive primary Sjogren's syndrome","volume":"28","author":"Katano","year":"2001","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0180","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","article-title":"Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.clim.2017.03.017_bb0185","first-page":"2012","article-title":"Prevalence and longterm course of primary biliary cirrhosis in primary Sjogren's syndrome","volume":"35","author":"Hatzis","year":"2008","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2017.03.017_bb0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-3083.2002.01165.x","article-title":"Do autoantibodies predict autoimmune liver disease in primary Sjogren's syndrome? Data of 180 patients upon a 5 year follow-up","volume":"56","author":"Csepregi","year":"2002","journal-title":"Scand. J. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2017.03.017_bb0195","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/rheumatology\/33.8.745","article-title":"Liver involvement in primary Sjogren's syndrome","volume":"33","author":"Skopouli","year":"1994","journal-title":"Br. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0205","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.2004.029603","article-title":"Anti-cyclic citrullinated peptide antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Tobon","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0210","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2420","article-title":"Anti-cyclic citrullinated peptide antibodies in primary Sjogren syndrome may be associated with non-erosive synovitis","volume":"10","author":"Atzeni","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.080193","article-title":"Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies","volume":"36","author":"Iwamoto","year":"2009","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2017.03.017_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcm015","article-title":"Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis","volume":"100","author":"Niewold","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.clim.2017.03.017_bb0225","series-title":"The Autoimmune Diseases","first-page":"1161","article-title":"Chapter 77 - autoantibody assays: performance, interpretation, and standardization A2 - Rose, Noel R","author":"Fritzler","year":"2014"},{"key":"10.1016\/j.clim.2017.03.017_bb0230","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.21.4.360","article-title":"Precipitating auto-antibodies in the connective tissue diseases","volume":"21","author":"Anderson","year":"1962","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.102.1.117","article-title":"Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus","volume":"102","author":"Clark","year":"1969","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0240","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI108007","article-title":"Antibodies to cellular antigens in Sjogren's syndrome","volume":"55","author":"Alspaugh","year":"1975","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.clim.2017.03.017_bb0245","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1073\/pnas.85.24.9479","article-title":"Molecular analysis of the 60-kDa human Ro ribonucleoprotein","volume":"85","author":"Deutscher","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1172\/JCI115003","article-title":"Molecular definition and sequence motifs of the 52-kD component of human SS-A\/Ro autoantigen","volume":"87","author":"Chan","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.clim.2017.03.017_bb0255","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2005.10.004","article-title":"The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure","volume":"5","author":"Wolin","year":"2006","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0260","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2005.11.029","article-title":"Autoantigen Ro52 is an E3 ubiquitin ligase","volume":"339","author":"Wada","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.clim.2017.03.017_bb0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.clim.2017.03.017_bb0270","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"17","key":"10.1016\/j.clim.2017.03.017_bb0275","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sjogren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clim.2017.03.017_bb0280","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sjogren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.clim.2017.03.017_bb0285","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2017.03.017_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2015.00181","article-title":"The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases","volume":"6","author":"Satoh","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2017.03.017_bb0295","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.clim.2017.03.017_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","article-title":"Ocular and systemic morbidity in a longitudinal cohort of Sjogren's syndrome","volume":"122","author":"Akpek","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.clim.2017.03.017_bb0305","first-page":"467","article-title":"Neonatal lupus: long-term outcomes of mothers and children and recurrence rate","volume":"15","author":"Brucato","year":"1997","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2017.03.017_bb0310","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/1529-0131(200103)44:3<647::AID-ANR113>3.0.CO;2-I","article-title":"Long-term outcome of mothers of children with isolated heart block in Finland","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:56:36Z","timestamp":1692737796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":62,"alternative-id":["S1521661617300104"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.03.017","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1186\/s12886-025-04050-7","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies, detection methods and panels for diagnosis of Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}